Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$278,962
-$194,501 QoQ
Shares Held
59,992
-62.0% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 57 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $734,488,194 across 28 Diagnostics & Research names. XGN ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,719,301 | $558,006,729 | |
| 2 | DHR |
Danaher Corp /De/
|
452,752 | $86,240,200 | |
| 3 | CDNA |
CareDx, Inc.
|
401,987 | $11,456,629 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
48,191 | $9,311,465 | |
| 5 | MYGN |
Myriad Genetics Inc
|
1,557,727 | $8,894,621 | |
| 6 | NTRA |
Natera, Inc.
|
32,600 | $8,849,270 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
17,014 | $8,530,139 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
400,986 | $8,228,232 |
All Filings in XGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $278,962 | 59,992 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $473,463 | 157,821 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,238,960 | 368,250 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,615,389 | 237,979 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $439,740 | 63,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||